Insulin-like growth factor binding protein 1 (IGFBP1), the main secretory product of the decidualized endometrium of a pregnant woman, has previously been shown to interact with the alpha 5 beta 1 integrin of extravillous trophoblast (EVT) cell surface to stimulate its migration in an IGF-independent manner. This migration stimulation has also been shown to require activation of extracellular signal regulated kinases 1 and 2 (ERK1/2; mitogen-activated protein kinase [MAPK] 3/1]) and focal adhesion kinase. The present study examined the roles of Rho GTPases RHOA, RHOC, RAC1, and CDC42 as well as RHO kinases ROCK1 and ROCK2 in IGFBP1-mediated migration of an immortalized EVT cell line HTR-8/SVneo. A nonselective RHO kinase inhibitor, Y27632, as well as siRNAs selective for ROCK1 and ROCK2 decreased the migration of these cells in a Transwell migration assay, and this inhibition could not be restored by IGFBP1. Clostridium difficile toxin B, which inhibits all the Rho GTPases, RAC inhibitor NSC23766, RAC1 siRNA, and CDC42 siRNA, decreased their basal migration, but none of these inhibitions except CDC42 siRNA-induced inhibition could be restored by IGFBP1. Clostridium botulinum C3 exoenzyme that inhibits RHOA, RHOB, and RHOC inhibited basal migration but not IGFBP1-induced migration. IGFBP1-induced activation of ERK1/2 (MAPK3/1), which did not require RHO proteins, might function as an alternate pathway for RHO action. However, selective siRNA-mediated downregulation of RHOA inhibited basal, but not IGFBP1-mediated, migration, whereas that of RHOC inhibited both basal and IGFBP1-mediated migration of these EVT cells. Therefore, RHO kinase, RHOC, and RAC1 are essential, but RHOA and CDC42 are not essential, for IGFBP1-induced EVT migration.
INTRODUCTION
Human trophoblasts are a highly proliferative population of cells derived from the outer layer of the blastocyst and destined to give rise to the chorion [1] [2] [3] [4] . Trophoblast cells play many parts in the human placenta depending on which of three pathways they take for differentiation. Villous trophoblasts ultimately fuse to form the syncytiotrophoblast layer over which fetal-maternal exchange can occur. Junctional trophoblasts proliferate at the point where the placenta makes contact with the uterus, mediating the anchorage of the chorionic villi to the endometrium throughout the duration of the pregnancy. Extravillous trophoblasts (EVTs) take on an invasive phenotype and migrate into the extracellular spaces of the maternal endometrium [1] [2] [3] [4] . Forming invasive cell columns, these EVT cells can either undergo a lateral migration to form the trophoblastic shell or a longitudinal migration to become the subpopulation of cells responsible for the deep invasion of the maternal decidua and myometrium [1] [2] [3] [4] [5] [6] . The ultimate goal of this invasion is the remodeling of the maternal spiral arteries, a process by which the arteries are transformed from lowconducting vessels with high resistance to blood flow into twisting vessels with low impedance, facilitating the exchange of blood between the mother and fetus. EVT cells that are destined for spiral artery remodeling must first undergo a transition from an epithelial-like phenotype to an endotheliallike phenotype [7] . These cells have been shown to acquire markers that identify this endothelial transition, particularly in terms of the alteration of the integrin repertoire of the EVT cells. Cytotrophoblast stem cells have been shown to express strongly the a 6 b 4 integrin, but differentiation toward the EVT cell lineage causes the cells to lose this integrin and gain the expression of both the a 5 b 1 and a 1 b 1 integrins [8] [9] [10] .
The migratory and invasive capability of EVT cells is tightly controlled throughout pregnancy, because both insufficient and excessive levels of EVT migration can result in different pathological states [11] . Thus, a balance must exist between factors that negatively regulate migration and those that promote migration, ensuring that the migratory process occurs in the proper spatial and temporal fashion. Factors that are involved in the migration of EVTs include various growth factors and their specific binding proteins, cell adhesion molecules, extracellular matrix proteins, as well as certain matrix metalloproteinases [2] . These molecules, along with various cytokines, can be produced by the decidua, the maternal microenvironment, or the trophoblasts themselves. One such molecule promoting EVT cell migration is insulinlike growth factor binding protein 1 (IGFBP1) [12] . In a pregnant woman, IGFBP1 is the main secretory product of the decidualized endometrium [13] and the most common IGFBP in amniotic fluid and fetal plasma [14] . Studies have also shown that whereas decidual production of IGFBP1 increases significantly during the first and second trimesters of pregnancy, women destined to develop preeclampsia show decreased levels of IGFBP1 in the serum, which may be indicative of decidual dysfunction [15] . IGFBP1 contains an Arg-Gly-Asp (RGD) sequence that is capable of recognizing and binding to certain integrins. It has been shown that the binding of the IGFBP1 RGD sequence to a recognition site on the a 5 b 1 integrin present on the cell surface stimulates migration of Chinese hamster ovary cells [16] and human EVT cells [17] [18] [19] .
A family of small GTP-binding proteins called RHO GTPase is critical for cell migration, mainly because of the distinct role(s) each member of this family plays in reorganizations of actin cytoskeleton [20] . In migrating cells, stress fibers are induced by GTP-bound RHOA or RHOC, whereas protrusion of lamellipodia and filopodia are induced by GTP-bound RAC1 and CDC42, respectively [21, 22] . Furthermore, very important downstream effectors of RHOA and RHOC are two serine/threonine kinases called ROCK1 and ROCK2. Activation of any one of the ROCKs by RHOA or RHOC blocks the activity of myosin light-chain (MLC) phosphatase, leading to an increase in phosphorylated MLCs and in cell contractility [23] . Activation of the RHO family members has been shown to mimic different extracellular factor-induced actin cytoskeletal remodeling required for various cellular functions, including cell migration. However, whether either GTPase is required for IGFBP1-mediated cell migration remains unknown. The present study was designed to determine whether ROCK1, ROCK2, RHOA, RHOC, RAC1, and CDC42 are required for IGFBP1-mediated migration of human EVT cells.
MATERIALS AND METHODS

Reagents
RPMI 1640 and fetal bovine serum (FBS) were purchased from Life Technologies, Inc. Native human IGFBP1 was purchased from GroPrep. Y27632, an inhibitor of ROCK, was purchased from Biomol International, LP. RAC inhibitor NSC23766 was purchased from Calbiochem. Clostridium difficile toxin B, an inhibitor of the entire RHO GTPase family, was purchased from Sigma. For migration assays, Transwells (pore size, 8 lm) were purchased from Costar. Luminescence-based RHOA and RHO activation G protein enzyme-linked immunosorbent assay (G-LISA) kits and cell-permeable RHO protein inhibitor C. botulinum C3 exoenzyme were purchased from Cytoskeleton. Reagents used for real-time PCR were obtained from Sigma. All the siRNA oligonucleotides used for silencing human RHOA, RHOC, RAC1, CDC42, ROCK1, and ROCK2, as well as the transfection reagent DharmaFECT, were purchased from Dharmacon, Inc. Alexa Fluor 488 phalloidin and TOTO-3 iodide 642/660 used for staining F-actin were obtained from Invitrogen Molecular Probes. Vectashield mounting medium was obtained from Vector Laboratories.
Human Trophoblast Cell Line
The present study employed a human EVT cell line known as HTR-8/ SVneo, developed and described by Graham et al. [24] . This is an immortalized cell line derived from a primary EVT cell line called HTR-8. HTR-8/SVneo cells retain abilities characteristic of EVT cells in situ in terms of proliferation, migration, and invasion, and they express all the typical markers of EVT cells in situ, which include cytokeratin-7, a 5 b 1 integrin, and human leukocyte antigen G. These cells also exhibit anchorage-dependent growth and are nontumorigenic in nude mice. In our laboratory, after every 25 passages, we characterize this cell line for the presence of EVT markers. The present study employed cells of between passage 100 and passage 130. Cells were cultured in RPMI 1640 medium supplemented with 10% FBS, 100 U/ml of penicillin, and 100 lg/ml of streptomycin.
Migration Assays
A Transwell migration assay was employed as previously described with respect to this cell line by Shields et al. [25] and Nicola et al. [26] . The present assays, however, were performed for 48 h, because IGFBP1 was previously shown to have maximal stimulation at this time point [19] . This assay uses 24-well Transwell plates containing cell-permeable inserts with pores of 8 lm through which HTR-8/SVneo cells can migrate. Cells were treated according to the particular experimental design and were then lifted, resuspended, and counted, along with a set of control cells. Cells (1 3 10 5 cells/ml) were added on the upper wells of the Transwell plates and allowed to migrate for 48 h at 378C in 5% CO 2 . Following the incubation period, cells that had migrated to the outer membrane were fixed and stained (nonmigratory cells were swabbed away from the inner membrane of the insert). Cells were fixed to the outer membrane in methanol for 2 min. They were then incubated in a phosphatebuffered eosin solution for 5 min to stain the nuclei, followed by a brief incubation in phosphate-buffered thiazine to stain the cytoplasm. The inserts were rinsed with distilled water and the inner surface swabbed again to remove any remaining dye. The inserts were then allowed to air dry for 24 h before they were counted. Migration scores were obtained by counting total migratory cells on each insert membrane using a light microscope (4003 magnification).
Transfection of siRNA
The siRNA oligonucleotides were designed against human RHOA and human RHOC with reference to Pille et al. [27] . RAC1-and CDC42-specific siRNA oligonucleotides were prepared by Dharmacon, Inc., using the sequences published by Noritake et al. [28] and Wilkinson et al. [29] , respectively. Additionally, siRNA oligonucleotides specific for both ROCK1 and ROCK2 were purchased from Dharmacon, Inc. All these siRNAs were shown to significantly downregulate expressions of the respective genes and the corresponding proteins in HTR-8/SVneo cells [25, 26, 30] .
In preparation for siRNA transfection, cells were plated in a six-well plate at a density of 1 3 10 5 cells/well and allowed to grow to 70%-90% confluence in RPMI 1640 medium supplemented with 10% FBS. Next, 4 ll/ml of DharmaFECT transfecting agent and the respective siRNAs were individually diluted in serum-free media without antibiotics, following which the two mixtures were allowed to incubate for 5 min. The two mixtures were then combined and allowed to incubate for another 20 min to allow the siRNA to complex with the transfecting agent. The siRNA in the mixture was brought to a final concentration of 100 nM through the addition of RPMI 1640 supplemented with 10% FBS, and a total volume of 2 ml of the siRNA was added to each well. The reaction was allowed to continue for 48 h.
RHO and RAC Activation Assays
RAC1, RHOA, or RHO G-LISA kits, which measure the combined levels of GTP-loaded RHOA, RHOB, and RHOC in cells, from Cytoskeleton, Inc., were employed to evaluate the activation status of RAC1, RHOA, or all three RHOs in response to IGFBP1 treatment over various time points.
Immunoassay of Phosphorylated Extracellular Signal Regulated Kinases
An immunoassay kit (Super Array Bioscience Corp.) specific to phosphorylated extracellular signal regulated kinase (ERK) was used to determine the effect of IGFBP1 on the activation status of these proteins. EVT cells were grown to 80% confluence in six-well plates and treated with IGFBP1 for 0, 5, 12, and 30 min. Cells were then washed with ice-cold PBS and harvested in 100 ll of lysis buffer using a cell scraper. Cell extracts were clarified by centrifugation for 2 min at 10 000 3 g and 48C. The clarified extracts were then quantified and equalized before beginning the immunoassay. A serial dilution of activated standard was done to produce the standard curve for the assay. Next, 100 ll of standard or sample were added to the appropriate microtiter wells. The plate was then incubated at room temperature for 2 h. The wells were washed four times, 100 ll of anti-phosphorylated ERK solution were added to each well, and the plate was incubated at room temperature for 1 h. Following washing, 100 ll of anti-rabbit immunoglobulin G-horseradish peroxidase were added to each well, and the plates were incubated for 30 min at room temperature. The wells were again washed four times, and 100 ll of stabilized chromogen were added to each well and incubated for 30 min at room temperature in the dark. Stop solution (100 ll) was added to each well, the plate was tapped gently to mix, and the absorbance of each well was read at 450 nm. The standard curve was created using Microsoft Excel software, and the protein concentrations of each well were determined using the equation generated from the standard curve.
Real-Time RT-PCR
Total RNA from siRNA-transfected cells was isolated using TRIzol Reagent (Life Technologies, Inc.) following the manufacturer's protocol, and cDNA was synthesized using total RNA primed with oligo(dT) as described in SuperScript (Invitrogen). Real-time PCR was used to measure the effectiveness of siRNA gene silencing by quantifying the relative mRNA levels of the silenced gene as compared to a control group. Real-time PCR was performed for RHOA, RHOC, RAC1, CDC42, ROCK1, ROCK2, and GAPDH using the SYBR Green Jumpstart Taq ReadyMix (Sigma). The primer sequences were published previously [25] . Reactions were done in single microcapillary tubes in the LightCycler (Roche Diagnostic). Each reaction capillary contained 10 ll of SYBR reagent, 2 ll of cDNA, 1.6 ll of 25 nM MgCl 2 , and 0.8 ll of 25 pmol/ll primer mixture. Once prepared, samples were cycled at 958C for denaturation (0 sec), 558C for annealing (5 sec), 728C for extension (24 sec), and 808C for detection of the SASO ET AL. signal (1 sec). Detected mRNA samples for both control groups and samples were normalized to GAPDH expression using the LightCycler software before further analysis of the siRNA-induced downregulation of gene expression.
Staining for F-Actin and Confocal Microscopy
Confocal microscopic images of EVT cell F-actin distribution were obtained following treatment with various inhibitors of the Rho GTPases. EVT cells were seeded onto 12-mm glass coverslips and left for 24 h in complete media to allow cell attachment. Cells were then washed in SFM medium with 0.1% bovine serum albumin and treated with one of the pharmacological inhibitors (Y27632, 20 lM, 30 min; NSC27366, 100 lM, 30 min; C3, 800 nM, 3 h; toxin B, 83 nM, 2 h) [25] . A subset of these cells was then treated with IGFBP1 for 48 h. Steps for staining the cells were as follows: Cells were washed twice with PBS and then subjected to 4% paraformaldehyde for 10 min to fix the cells. The cells were again washed twice for 5 min each time with PBS and permeabilized using Triton-X (15 min). Following another PBS wash (two washes for 5 min each), cells were incubated under lightsensitive conditions with Alexa Fluor 488 (40 min) to stain F-actin and TOTO-3 iodide 642/660 (5 min) to stain the nucleic acids (Molecular Probes). The coverslips were then mounted onto slides using a small droplet of Vectashield mounting medium (Vector Laboratories). Images were obtained at 403 magnification using a confocal microscope.
Statistical Analyses
Statistical analyses were performed using SPSS software (Version 12.0; SPSS, Inc.). Migration and proliferation assay results were converted to indices by normalizing each value as a percentage of the control. All the results were expressed as the mean 6 SEM. Fold-increases of migration indices in IGFBP1-treated cells compared to controls without inhibitor treatments were compared to those with inhibitor treatments, and the significant differences between these two groups were identified using two-way ANOVA. Dunnett test was performed for comparing each experimental mean with the control mean. Student t-tests were used to compare the mRNA levels after gene-specific siRNA transfections with those of their respective controls, as obtained by realtime RT-PCR. Differences at P , 0.05 were considered to be significant.
RESULTS
ROCK1 and ROCK2 Are Essential for IGFBP1-Mediated EVT Cell Migration
While optimizing the migration assay conditions, day-today variation was observed in the actual number of cells that migrated. In control groups, the number of cells that migrated varied from 80 to 250. However, the extent of stimulation or inhibition due to different treatments did not vary between days. For this reason, we expressed the migration assay results as a migration index (i.e., relative change with respect to control).
We used recombinant IGFBP1 at 250 ng/ml, a concentration that has been shown in our present study to have maximal stimulation of migration of HTR-8/SVneo cells in serum-free medium during a 48-h period without exhibiting any effect on cell survival. Pilot experiments indicated that the migration of HTR-8/SVneo cells induced by IGFBP1 occurs in a chemokinetic fashion, in that the frequency of migration is increased by the presence of IGFBP1 in the upper chamber of the Transwells. EVT cells do not undergo chemotactic stimulation by IGFBP1, as indicated by the cells not responding to the gradient produced by IGFBP1 in the lower chamber alone. Therefore, in all the subsequent migration assay experiments, we placed IGFBP1 in the upper chamber only.
Cell migration assay was performed to assess the involvement in this process of the RHO kinases, major downstream targets of RHO proteins. The RHO kinases ROCK1 and ROCK2 are inhibited by the pharmacological inhibitor Y27632, which works by competing for the ATP-binding site on these GTPases. As shown before [25] , we found that the ROCK inhibitor Y27632 at 20 lmol/L was more effective than Rho GTPase IN IGFBP1-INDUCED TROPHOBLAST MIGRATION at 10 lmol/L to inhibit EVT cell migration. We optimized a pretreatment of the cells with Y27632 for 30 min. Results from the migration assay showed a significant (40%) decrease in basal migration rate (Fig. 1A ) in response to inhibition of the RHO kinases, indicating that these molecules also are required for basal EVT migration.
We next investigated whether these enzymes were required by IGFBP1 to stimulate EVT cell migration. Whereas IGFBP1 treatment of the control cells exhibited approximately 2-fold stimulation, that of the cells pretreated with Y27632 did not exhibit any stimulation of their migration, but the cells remained viable. These results, though suggesting the requirement of RHO kinase in IGFBP1-mediated EVT cell migration, do not suggest whether both ROCK1 and ROCK2 are required for IGFBP1 function. Using the same set of respective siRNA as Shields et al. [25] and Nicola et al. [26, 30] , we were able to downregulate either ROCK1 or ROCK2 mRNA levels in HTR-8/SVneo cells over 75%. As shown before [25] , these siRNA sets also inhibited ROCK1 and ROCK2 proteins in this cell line. These ROCK1-and ROCK2-silenced cells were then subjected to migration assays in the presence or absence of IGFBP1. Silencing of ROCK1 inhibited basal migration of these cells by 80% (Fig. 1B) , whereas silencing of ROCK2 inhibited migration by 50% (Fig. 1C) . IGFBP1 was not able to stimulate migration of either ROCK1-or ROCK2-silenced cells (Fig. 1, B and C) .
RHOA Is Dispensable, But RHOC Is Essential, for IGFBP1-Mediated EVT Cell Migration
Clostridium botulinum C3 exoenzyme specifically inhibits RHOA, RHOB, and RHOC, through ADP-ribosylation, but not RAC or CDC42 GTPases. We optimized a pretreatment of the cells with 800 nM of C3 exoenzyme for 3 h. Analysis of the migration assay showed that the inactivation of the RHO proteins by C3 exoenzyme led to a significant reduction (33%) in the basal migration of EVT cells but not the IGFBP1-induced migration of HTR-8/SVneo cells ( Fig. 2A) . The cells remained viable at least until 48 h of treatment.
Although RHOB has been implicated in intracellular trafficking and cell survival, both RHOA and RHOC have been implicated in cell migration. Therefore, to determine the role of RHOA or RHOC independently, we silenced either of these two in HTR-8/SVneo cells. As reported before [25] , both RHOA and RHOC mRNA levels in the present study also were shown to be inhibited more than 70% by the respective siRNA when compared with the control siRNA-transfected cells. The siRNA-mediated effects were specific, because real-time PCR data showed no change in RHOA mRNA levels after RHOC siRNA transfection, and vice versa. Western blot analyses further confirmed downregulation of these proteins by the respective siRNAs. Downregulation of RHOA in the present study inhibited basal migration of these cells by more than 60% (Fig. 2B) , whereas downregulation of RHOC inhibited basal migration by more than 70% (Fig. 2C) . When RHOA-silenced cells and the control siRNA-treated cells were both exposed to IGFBP1, we found that the extents of IGFBP1-induced stimulations of migration were not different in these groups (Fig. 2B) . However, IGFBP1 was not able to induce any stimulation of migration of RHOC-silenced HTR-8/SVneo cells (Fig. 2C) .
RAC1 Is Indispensable, But CDC42 Is Dispensable, for IGFBP1-Mediated EVT Cell Migration
Clostridium difficile toxin B enters the cell by endocytosis and inhibits all of the Rho GTPases (including RHO, RAC, and CDC42) through a monoglycosylation mechanism [31] . Preincubation of HTR-8/SVneo cells with 85 nM C. difficile toxin B for 2 h caused a significant (58%) decrease in basal EVT cell migration as compared to control levels (Fig. 3A) . More importantly, this inhibitory effect of toxin B on cell migration could not be overcome by the addition of IGFBP1 to these toxin B-exposed cells (Fig. 3A) . These results, along with those shown in Figure 2A , indicate that when RAC and SASO ET AL.
CDC42 were intact, IGFBP1 was able to recover the migration inhibitory effects of C3 exoenzyme inactivating only the RHO proteins. However, in the absence of all the members of RHO GTPase family, it was not able to exhibit any effect on cell migration.
To investigate whether both RAC and CDC42 are equally important or if one is more important than the other for IGFBP1 action, we then inhibited either RAC or CDC42 in HTR-8/SVneo cells. To investigate the effect of RAC1 inhibition on IGFBP1-induced EVT cell migration, we used 100 lmol/L of NSC23766, because this concentration has been shown previously to be optimal for inhibition of RAC1 GTPase and cellular migration [25, 32, 33] . NSC23766 inhibits RAC GTPase by interrupting the interaction between the GTPase and its specific guanine nucleotide exchange factor, thus blocking the activation of the RAC protein [32, 33] . Preincubation of HTR-8/SVneo cells with 100 lM NSC23766 for 30 min caused a 50% reduction in the basal rate of EVT cell migration (Fig. 3B) , and IGFBP1 was not able to reverse this inhibitory effect (Fig. 3B) . As shown in Figure  3C , IGFBP1 was also not able to reverse the effect of selective inhibition of RAC1 by the same set of siRNA as used before [25] . However, because RAC1 was not activated by IGFBP1 (data not shown), RAC1 most likely plays a permissive role for IGFBP1-mediated EVT cell migration. On the other hand, selective inhibition of CDC42 by siRNA [25] did not hamper the activity of IGFBP1 to stimulate EVT cell migration (Fig.  3D) . Rather, IGFBP1 worked better when CDC42 was inhibited, because the extent of stimulation was more when IGFBP1 was added to CDC42-silenced cells than when it was added to control siRNA-transfected cells (Fig. 3D) .
IGFBP1 Induces Actin Cytoskeletal Reorganization in Cultured EVT Cells
The process of F-actin reorganization, which plays important roles in cell migration, is under tight regulation of Rho GTPases. We investigated the ability of IGFBP1 to induce changes in reorganization of F-actin of HTR-8/SVneo cells. Phalloidin staining of HTR-8/SVneo cells exposed to cellpermeable C3 exoenzyme showed perturbation of cell shape, great reduction of actin stress fibers, and strong actin staining at the edges of the cells when compared with the control cells (Fig. 4) . After addition of IGFBP1, a more robust stress fiber network (arranged in parallel arrays) appeared within C3-exposed cells compared to that within control cells (Fig. 4) . These results are in accordance with the migration assay results shown in Figure 2A . HTR-8/SVneo cells exposed to Y27362, toxin B, or NSC23766 underwent retraction and exhibited disruption of actin cytoskeleton (Fig. 4) . Further exposure of these cells to IGFBP1, however, did not cause any significant change in actin cytoskeletal reorganization (Fig. 4) . These morphological data also support the functional data on cell migration (Figs. 1, A-C, and 3 , A-C).
C3 Transferase Does Not Affect IGFBP1-Mediated ERK Signaling
The IGFBP1 was shown to stimulate the activities of neither RHOA nor RHOA, RHOB, or RHOC in HTR-8/SVneo cells both in the presence and absence of C3 exoenzyme (data not shown). However, the results presented earlier have shown that IGFBP1 can induce both the migration of EVT cells and stress Rho GTPase IN IGFBP1-INDUCED TROPHOBLAST MIGRATION fiber formation even in the presence of C3 exoenzyme (Fig. 4) . We therefore wondered if ERK (mitogen-activated protein kinase [MAPK] 3/1) could be responsible for IGFBP1-induced migration of C3-exposed EVT cells, because ERK (MAPK3/1) is known to activate MLC kinase (MLCK; or MYLK) and induce the phosphorylation of myosin, increasing the contractile capacity of the cell during migration [34, 35] . Furthermore, we have shown previously that ERK (MAPK3/1) is an important mediator of IGFBP1-induced migration of EVT cells [19] . In the present study, we tested the effect of IGFBP1 on the level of ERK (MAPK3/1) phosphorylation by an ELISA. As shown in Figure 5 , IGFBP1 induced phosphory- SASO ET AL. lation of ERK1/2, with a peak at 7 min. To test whether RHO protein(s) played any role in IGFBP1-induced ERK (MAPK3/ 1) phosphorylation, we incubated HTR-8/SVneo cells with 800 nM C3 transferase for 4 h, and then the cells were challenged with IGFBP1. As shown in Figure 5 , IGFBP1 treatment stimulated ERK (MAPK3/1) phosphorylation in C3-treated cells as well, though it took longer (peak at 30 min) to activate the enzyme in these cells.
DISCUSSION
We have previously provided evidence for IGFBP1 interaction with cell surface a 5 b 1 integrin stimulating the migration of first-trimester EVT cells [19] . It does so by activating ERK (MAPK3/1) and focal adhesion kinase (FAK; official symbol PTK) [19] . The present study has further demonstrated that IGFBP1 requires ROCK1, ROCK2, RHOC, and RAC1, but not RHOA and CDC42, for EVT cell migration; induces actin stress fiber formation; and can activate ERK (MAPK3/1) in the presence or absence of active RHO proteins in these cells. It is important to note the present study required an approximately 10-fold greater concentration of IGFBP1 than in our previous study [19] to obtain maximum stimulation of cell migration. This occurred because unlike the previous study, in which the migration assays were done under serum-reduced conditions, the present study used serum-free conditions for all the assays to avoid possible confounding factors in serum. It is possible that the presence of serum saturated the a 5 b 1 integrin sites on the EVT cell membranes.
Comparison of the present results with those of our previous studies [25, 26, 30] indicates that different members of the RHO GTPase family and ROCK1 and ROCK2 regulate EVT cell migration differentially, depending on which factor at the maternal-fetal interface sends the motility signal to these cells. For example, ROCK1 and ROCK2 are absolutely required for IGF-I, prostaglandin E 2 (PGE 2 ), and IGFBP1 to induce EVT cell migration, but they are not essential for IGF-II. Furthermore, neither RHOA nor RHOC may be required for IGF-II, RHOA is only partially required for PGE 2 , and RHOC is required, but RHOA is not obligatory, for IGFBP1 action on Rho GTPase IN IGFBP1-INDUCED TROPHOBLAST MIGRATION EVT cells. Finally, neither RAC1 nor CDC42 is required for IGFs, but both of them are necessary for PGE 2 . In addition, RAC1 is absolutely required, but CDC42 is not required, for IGFBP1 to stimulate EVT cell migration. However, whereas PGE 2 can activate RHOA, RAC1, and CDC42 in EVT cells, IGFBP1 is able to activate none of these GTPases. Therefore, the members of Rho GTPase family may have only permissive roles in IGFBP1-induced cell migration.
The present results further show that in the presence of IGFBP1, RHOC can compensate for the loss of RHOA in EVT cells, but RHOA cannot compensate for the loss of RHOC. However, even when all three RHO proteins were inactivated, IGFBP1 was able to compensate for the loss of all of them. This may indicate that when IGFBP1 is produced during normal pregnancy by the decidua, the negative regulatory influence of RHOB [22] on cell migration is stronger than the positive regulatory influence of RHOA and RHOC in EVT cells.
Though CDC42 is known to promote cell migration by protruding filopodia, we have found the CDC42-silenced EVT cells to migrate in the presence of IGFBP1. In some previous studies, CDC42-independent filopodia formation and cell migration were shown to depend on the presence of other proteins, such as Ras-like GTPase A (RALA) and lipid phosphatase-related protein 1 (LPR1) [36, 37] . Further studies will be necessary to elucidate whether any of these proteins is required for CDC42-independent migration of EVT cells triggered by IGFBP1.
Mitogen-activated protein kinases are known to participate in cell proliferation, apoptosis, migration, and differentiation [38, 39] . Previous studies have demonstrated that transient activation of ERK (MAPK3/1) plays a pivotal role in cell proliferation and migration but that sustained ERK (MAPK3/1) activation induces cell-cycle arrest, apoptosis, and differentiation [39, 40] . In contrast to PGE 2 , IGFBP1 may partially deactivate ERK (MAPK3/1), regardless of RHO status. This also suggests that whereas PGE 2 utilizes ERK (MAPK3/1) for other cellular functions in addition to migration, IGFBP1 utilizes them mainly for cell migration. The present results suggest that RHO proteins (RHOA, RHOB, and RHOC) do not play any significant role in ERK1/2 phosphorylation. Rather, ERK (MAPK3/1) might serve as an alternate pathway for RHO action during IGFBP1-induced migration of HTR-8/SVneo cells. Though IGFBP1 took longer to activate ERK (MAPK3/ 1) when the cells were treated with C3 exoenzyme, the extent of ERK activation was greater in the C3-treated cells than in the control cells. This further suggests that some of the RHO proteins exert a tonic inhibitory influence on ERK (MAPK3/1) and that this inhibition is removed by the presence of IGFBP1.
Based on our previous [19] and present results, we propose a model (Fig. 6 ) to summarize the signal transduction pathways that might regulate human trophoblast migration induced by IGFBP1. Interaction of decidua-derived IGFBP1 with a 5 b 1 integrin on the EVT membrane may result in activation of PTK2 (FAK), which may in turn activate ERK (MAPK3/1), most likely through sequential activation of RAS, RAF, and MEK. Whereas phospho-PTK2 stimulates adhesion of EVT, possibly through its association with paxillin, phosphorylated ERK (phosphorylated MAPK3/1) may stimulate formation of actin stress fibers through activation of MLCK (MYLK). Contraction of these fibers can generate force required for EVT migration. RHO proteins (RHOA, RHOB, and RHOC) are known to play pivotal roles in actin stress fiber formation, but effects of simultaneous inactivation of all three proteins can easily be compensated for if IGFBP1 is present in the trophoblast microenvironment. This compensation most probably is provided by the activated ERK (MAPK3/1). We have further shown that IGFBP1 can stimulate EVT migration independent of RHOA but not independent of RHOC. Therefore, RHOC may stimulate ROCK, which in turn phosphorylates MLCK (MYLK). Finally, RAC1, which causes lamellipodial extension, was found to be essential for IGFBP1-induced EVT migration.
Therefore, although several factors in the maternal-fetal interface are able to promote EVT migration, they may not be functionally redundant, because different factors in the maternal-fetal interface have differential requirements of intracellular signaling molecules, including the members of the RHO GTPase family. However, further experiments showing the effects of IGFBP1 in trophoblasts in situ isolated from first-trimester placental tissues are warranted to demonstrate true functionality of IGFBP1 on human EVT.
